Joincare Pharmaceutical Group Industry Co Ltd, a leading mainland maker of health products, has reevaluated its market value following the recent completion of an equity investment deal and ahead of an upcoming new share issue.Equity-invested listed companies have been required to revaluate their market value following the introduction of new accounting standards on January 1 2007. Since their reciprocal share-holding is calculated based on market value, this significantly raises the market value of listed companies that hold large amounts of corporate shares or directly hold tradable shares. Joincare is a particularly attractive investment due to the scale of its equity investment. On February 10 2007,

You are currently reading 108 words of 329 total words in this article.
To continue reading this article, you must be a subscriber. Log in now..

Finish this article for free.
@2017 China Economy @ China Perspective.
All Right Reserved.
Server SSL Certificate